Other
Running the Biopharma Marathon
 | When I moved to Boston over thirty years ago, I had never even heard of the Boston Marathon. I grew up in the Midwest and moved to the West Coast for a district sales manager role. Boston, let alone the Marathon, just wasn’t part of my world. All that changed when I moved to Newton, to a… Read the full article… |
“Rare Disease” Is More Than Just a Day
 | “It is important for all of us to appreciate where we come from and how that history has really shaped us in ways that we might not understand.” Justice Sotomayor You might think it odd for me to begin this month’s e-conversation with a quote from a Supreme Court justice. However, this insight has stuck with me… Read the full article… |
Appreciation for Interconnectedness
 | It was precisely two years ago this month — March 2020 — when I wrote the first sentences of issue #30 of this e-conversation. At the time, I acknowledged the WHO’s declaration that COVID-19 had reached the threshold of a global pandemic. The remainder of that issue was about how to be productive working remotely.… Read the full article… |
Moments That Matter
 | I was in Austin, Texas last week to commemorate my father’s 89th birthday. It would be a noteworthy milestone under any circumstances — but given the suffering so many have endured during the pandemic, it was a special joy to celebrate with him in person. But there is more to this story. You see, my… Read the full article… |
Summer Internships: Mutually Beneficial for All
 | Earlier this year, we decided to hire two Project Onramp summer interns for Corval, our new startup. First, because we needed the help (!) and second, because we are committed to walking the talk of this important Life Science Cares program. (Project Onramp creates paid summer internships for Massachusetts college students who are under-resourced and… Read the full article… |
Freedom to Lead
 | In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies. Anyone who knows me won’t be surprised that I am an advocate for the concept, having seen so many talented people bogged down in fragmented planning processes,… Read the full article… |
Pandemic-Inspired Thought Bubbles
 | As we emerge, slowly, into a new phase of the pandemic, there are many “thought bubbles” popping up — viewpoints, concerns, and ideas that we share with others or keep to ourselves as we try to manage the present and anticipate the future. Here is just a sample of what I have heard… “People need… Read the full article… |
Notes from the Un-Empty Nest
 | My son, Jonathan, calls it “Mom-toring” — professional mothers (or parental surrogates) mentoring their adult professional kids. It applies whether or not those kids live at home, but there seems to be a specific and new shared experience when, thanks to the pandemic, the generations are back together living under the same roof. The more… Read the full article… |
Reverse Mentoring with Up-and-Coming Talent
 | In the accelerated, high-stakes world of biopharma, thinking big, thinking fast, and thinking smart, isn’t just an option — it’s a priority. Why then, are we not tapping into our most educated generation and exploring what millennials have to offer? (A rhetorical question, for sure.) Millennials bring a unique viewpoint, one that not only enables… Read the full article… |
Commercialization Street Smarts to Inform Your S-1 Business Section
 | Over the past several years, The NemetzGroup has worked with numerous clients to develop key aspects of their S-1 filings — coordinating with bankers, attorneys, internal staff, and many more attorneys, all with the goal of helping these companies achieve successful public offerings. Within the S-1, effective crafting of the Business Section is critical. If you… Read the full article… |